22 - CLAP

936. Fransen L, Klauss V. Neonatal ophthalmia in the developing world. Epidemiology, etiology, managementand control. Int Ophthalmol. 1988 Jan;11(3):189-96.937. Hammerschlag MR. Neonatal ocular prophylaxis. Pediatr Infect Dis J. 1988 Feb;7(2):81-2.938. Hammerschlag MR, Cummings C, Roblin PM, Williams TH, Delke I. Efficacy of neonatal ocularprophylaxis for the prevention of chlamydial and gonococcal conjunctivitis. N Engl J Med. 1989 Mar23;320(12):769-72.939. Isenberg SJ, Apt L, Campeas D. Ocular applications of povidone-iodine. Dermatology. 2002;204Suppl 1:92-5.940. Isenberg SJ, Apt L, Wood M. The influence of perinatal infective factors on ophthalmia neonatorum. JPediatr Ophthalmol Strabismus. 1996 May-Jun;33(3):185-8.941. Isenberg SJ, Apt L, Wood M. A controlled trial of povidone-iodine as prophylaxis against ophthalmianeonatorum. N Engl J Med. 1995 Mar 2;332(9):562-6.942. Kibel MA. Silver nitrate and the eyes of the newborn—a centennial. S Afr Med J. 1981 Dec26;60(26):979-80.943. Kramer A. New aspects in prophylaxis of ophthalmia neonatorum (Crede prophylaxis). Wien KlinWochenschr. 2002 Mar 28;114(5-6):171-2.944. Kramer A, Aspock C, Assadian O, et al. Prophylactic indications for eye antiseptics. Prophylaxis againstophthalmia neonatorum. Dev Ophthalmol. 2002;33:223-32.945. Laga M, Plummer FA, Piot P, et al. Prophylaxis of gonococcal and chlamydial ophthalmia neonatorum.A comparison of silver nitrate and tetracycline. N Engl J Med. 1988 Mar 17;318(11):653-7.946. Lund RJ, Kibel MA, Knight GJ, van der Elst C. Prophylaxis against gonococcal ophthalmia neonatorum.A prospective study. S Afr Med J. 1987 Nov 7;72(9):620-2.947. Nishida H, Risemberg HM. Silver nitrate ophthalmic solution and chemical conjunctivities. Pediatrics.1975 Sep;56(3):368-73.948. No authors listed. American Academy of Pediatrics Committees: prophylaxis and treatment of neonatalgonococcal infections. Pediatrics. 1980 May;65(5):1047-8.949. No authors listed. Recommendations for prevention of neonatal ophthalmia. Infectious Diseases andImmunization Committee, Canadian Paediatric Society. Can Med Assoc J. 1983 Sep 15;129(6):554-5.950. Raucher HS, Newton MJ. New issues in the prevention and treatment of ophthalmia neonatorum. AnnOphthalmol. 1983 Nov;15(11):1004, 1006-9.951. Salpietro CD, Bisignano G, Fulia F, Marino A, Barberi I. Chlamydia trachomatis conjunctivitis in thenewborn Arch Pediatr. 1999 Mar;6(3):317-20.952. Schaller UC, Klauss V. Is Crede’s prophylaxis for ophthalmia neonatorum still valid? Bull World HealthOrgan. 2001;79(3):262-3.953. Schaller UC, Klauss V. Ophthalmia neonatorum Klin Monatsbl Augenheilkd. 2001Nov;218(11):A200-2.954. Schneider G. Silver nitrate prophylaxis. Can Med Assoc J. 1984 Aug 1;131(3):193-6.955. Zanoni D, Isenberg SJ, Apt L. A comparison of silver nitrate with erythromycin for prophylaxis againstophthalmia neonatorum. Clin Pediatr (Phila). 1992 May;31(5):295-8.956. Zola EM. Evaluation of drugs used in the prophylaxis of neonatal conjunctivitis. Drug Intell ClinPharm. 1984 Sep;18(9):692-6.MANUAL CLÍNICO AIEPI NEONATAL 124